NEW YORK (GenomeWeb) – The National Institutes of Health announced last week it will award $8 million to study the molecular interactions between pathogens and hosts that are associated with antibacterial-resistant infection.

The National Institute of Allergy and Infectious Diseases will commit $8 million in Fiscal Year 2016 to fund up to five awards.  Total costs of up to $2 million per year may be requested, with a maximum project period of five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.